Apple CEO's Silence Says More Than His PR Team

Phew. Apple Inc.’s iconic Chief Executive Steve Jobs does not have a recurrence of the pancreatic cancer he successfully battled four years ago.

At least that is what investors learned by reading the New York Times, in an odd culmination of events that started last week, after Apple (AAPL) reported its second-quarter earnings and an analyst gently asked about Jobs’s health on the conference call.

Chief Financial Officer Peter Oppenheimer’s reply that Jobs “has no plans to leave Apple” and that his “health is a private matter” did nothing to assuage investors’ fears that the legendary CEO could be ill again, based on his gaunt appearance at Apple’s Worldwide Developers Conference in June and renewed media speculation last week.

Read the rest of this post